ARQ INC (ARQ) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:ARQ • US00770C1018

3.8 USD
-0.05 (-1.3%)
At close: Feb 11, 2026
3.8 USD
0 (0%)
After Hours: 2/11/2026, 8:06:49 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Taking everything into account, ARQ scores 3 out of 10 in our fundamental rating. ARQ was compared to 83 industry peers in the Chemicals industry. ARQ has a bad profitability rating. Also its financial health evaluation is rather negative. ARQ is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • ARQ had negative earnings in the past year.
  • In the past year ARQ had a positive cash flow from operations.
  • ARQ had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: ARQ reported negative operating cash flow in multiple years.
ARQ Yearly Net Income VS EBIT VS OCF VS FCFARQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • ARQ's Return On Assets of -1.41% is in line compared to the rest of the industry. ARQ outperforms 40.96% of its industry peers.
  • With a Return On Equity value of -1.81%, ARQ perfoms like the industry average, outperforming 49.40% of the companies in the same industry.
Industry RankSector Rank
ROA -1.41%
ROE -1.81%
ROIC N/A
ROA(3y)-3.97%
ROA(5y)1.37%
ROE(3y)-5.19%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A
ARQ Yearly ROA, ROE, ROICARQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100

1.3 Margins

  • Looking at the Gross Margin, with a value of 33.36%, ARQ is in the better half of the industry, outperforming 66.27% of the companies in the same industry.
  • ARQ's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ARQ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.52%
GM growth 5Y4.26%
ARQ Yearly Profit, Operating, Gross MarginsARQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • ARQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ARQ has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ARQ has been increased compared to 5 years ago.
  • Compared to 1 year ago, ARQ has an improved debt to assets ratio.
ARQ Yearly Shares OutstandingARQ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ARQ Yearly Total Debt VS Total AssetsARQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 2.35 indicates that ARQ is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ARQ has a better Altman-Z score (2.35) than 62.65% of its industry peers.
  • A Debt/Equity ratio of 0.11 indicates that ARQ is not too dependend on debt financing.
  • ARQ's Debt to Equity ratio of 0.11 is amongst the best of the industry. ARQ outperforms 87.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 2.35
ROIC/WACCN/A
WACC14.67%
ARQ Yearly LT Debt VS Equity VS FCFARQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

2.3 Liquidity

  • ARQ has a Current Ratio of 1.10. This is a normal value and indicates that ARQ is financially healthy and should not expect problems in meeting its short term obligations.
  • ARQ has a worse Current ratio (1.10) than 89.16% of its industry peers.
  • ARQ has a Quick Ratio of 1.10. This is a bad value and indicates that ARQ is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.71, ARQ is doing worse than 87.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.71
ARQ Yearly Current Assets VS Current LiabilitesARQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • ARQ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -700.00%.
  • The Revenue has been growing slightly by 7.20% in the past year.
  • Measured over the past years, ARQ shows a quite strong growth in Revenue. The Revenue has been growing by 9.22% on average per year.
EPS 1Y (TTM)-700%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-175%
Revenue 1Y (TTM)7.2%
Revenue growth 3Y2.8%
Revenue growth 5Y9.22%
Sales Q2Q%0.86%

3.2 Future

  • The Earnings Per Share is expected to grow by 42.41% on average over the next years. This is a very strong growth
  • ARQ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.19% yearly.
EPS Next Y-12.02%
EPS Next 2Y-36.19%
EPS Next 3Y34.3%
EPS Next 5Y42.41%
Revenue Next Year7.96%
Revenue Next 2Y11.55%
Revenue Next 3Y15.37%
Revenue Next 5Y17.19%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ARQ Yearly Revenue VS EstimatesARQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
ARQ Yearly EPS VS EstimatesARQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ARQ. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ARQ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARQ Price Earnings VS Forward Price EarningsARQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ARQ is valued a bit more expensive than the industry average as 62.65% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.6
ARQ Per share dataARQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • ARQ's earnings are expected to grow with 34.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-36.19%
EPS Next 3Y34.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ARQ does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARQ INC

NASDAQ:ARQ (2/11/2026, 8:06:49 PM)

After market: 3.8 0 (0%)

3.8

-0.05 (-1.3%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-05
Earnings (Next)03-03
Inst Owners39.02%
Inst Owner ChangeN/A
Ins Owners18.63%
Ins Owner Change-0.12%
Market Cap162.22M
Revenue(TTM)117.94M
Net Income(TTM)-3.92M
Analysts82.22
Price Target8.67 (128.16%)
Short Float %4.41%
Short Ratio3.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-184.29%
Min EPS beat(2)-278.18%
Max EPS beat(2)-90.4%
EPS beat(4)2
Avg EPS beat(4)-42.15%
Min EPS beat(4)-278.18%
Max EPS beat(4)100%
EPS beat(8)4
Avg EPS beat(8)2.78%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.23%
Min Revenue beat(2)0.63%
Max Revenue beat(2)9.82%
Revenue beat(4)3
Avg Revenue beat(4)1.51%
Min Revenue beat(4)-7.12%
Max Revenue beat(4)9.82%
Revenue beat(8)6
Avg Revenue beat(8)4.7%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.16%
PT rev (3m)-20.56%
EPS NQ rev (1m)-23.33%
EPS NQ rev (3m)-988.35%
EPS NY rev (1m)-13.49%
EPS NY rev (3m)-2340%
Revenue NQ rev (1m)-5.44%
Revenue NQ rev (3m)-14.47%
Revenue NY rev (1m)-1.36%
Revenue NY rev (3m)-2.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.38
P/FCF N/A
P/OCF 30.98
P/B 0.75
P/tB 0.77
EV/EBITDA 16.6
EPS(TTM)-0.08
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-1.07
FCFYN/A
OCF(TTM)0.12
OCFY3.23%
SpS2.76
BVpS5.09
TBVpS4.92
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.41%
ROE -1.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.36%
FCFM N/A
ROA(3y)-3.97%
ROA(5y)1.37%
ROE(3y)-5.19%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.52%
GM growth 5Y4.26%
F-Score5
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 2.49
Cap/Depr 467.23%
Cap/Sales 43.29%
Interest Coverage N/A
Cash Conversion 52.66%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.71
Altman-Z 2.35
F-Score5
WACC14.67%
ROIC/WACCN/A
Cap/Depr(3y)475.88%
Cap/Depr(5y)322.19%
Cap/Sales(3y)39.34%
Cap/Sales(5y)27.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-700%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-175%
EPS Next Y-12.02%
EPS Next 2Y-36.19%
EPS Next 3Y34.3%
EPS Next 5Y42.41%
Revenue 1Y (TTM)7.2%
Revenue growth 3Y2.8%
Revenue growth 5Y9.22%
Sales Q2Q%0.86%
Revenue Next Year7.96%
Revenue Next 2Y11.55%
Revenue Next 3Y15.37%
Revenue Next 5Y17.19%
EBIT growth 1Y-270.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year658.57%
EBIT Next 3Y150.35%
EBIT Next 5Y102.03%
FCF growth 1Y7.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y119%
OCF growth 3Y-26.14%
OCF growth 5Y-29.98%

ARQ INC / ARQ FAQ

Can you provide the ChartMill fundamental rating for ARQ INC?

ChartMill assigns a fundamental rating of 3 / 10 to ARQ.


Can you provide the valuation status for ARQ INC?

ChartMill assigns a valuation rating of 1 / 10 to ARQ INC (ARQ). This can be considered as Overvalued.


How profitable is ARQ INC (ARQ) stock?

ARQ INC (ARQ) has a profitability rating of 2 / 10.


What is the financial health of ARQ INC (ARQ) stock?

The financial health rating of ARQ INC (ARQ) is 3 / 10.